Read More

Canadian Cannabis Flower Power: Who Are The Top Players? What Happened In Q2 2023?

Zuanic & Associates' recent report unveils the movers and shakers in the flower segment, shedding light on their market shares, pricing strategies and fortunes. The second quarter of 2023 saw some intriguing shifts in the sector.

CRON

Read More

EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy In Kids

NeurAxis Inc (NYSE: NRXS) highlighted A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients with Post-Concussion Syndrome (PCS), a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of IB-Stim in children with post-conc

NRXS

Read More

From Deceit To Deliverance: US Cannabis On The Verge Of A Breakthrough

Red and white, blue suede shoes, I'm Uncle Sam, how do you do? Gimme five, I'm still alive, ain't no luck, I learned to duck. It’s been a long, hard road for U.S. cannabis, one that if we follow far enough back will take us to a place where the United States did things that the United States shouldn’t be particularly proud of.

GLASF

Read More

Season 2 Coming Soon: Weedmaps & ‘The Freak Brothers’ Partner To Destigmatize Cannabis, Learn More At Game-Changing Conference

WM Technology, Inc. known as Weedmaps (NASDAQ: MAPS), and WTG Enterprises, the production company behind the long-standing stoner comic series 'The Freak Brothers,' have announced a strategic partnership to further destigmatize and celebrate

MAPS